THE BONNIE J. ADDARIO Lung Cancer Foundation (ALCF) and the EGFR Resisters, a patient-driven community of people living with epidermal growth factor receptor (EGFR)-positive lung cancer, are working together to raise funds and increase awareness of projects that benefit the EGFR-positive cancer community.
Bonnie J. Addario
“ALCF was founded to bring [patients with] lung cancer into the conversation,” said Bonnie J. Addario, 14- year lung cancer survivor and ALCF founder. “We exist to support patient collaboration, and our partnership with the EGFR Resisters is a perfect example of that principle in action.”
“We’re excited about the possibilities this collaboration offers,” said Ivy Elkins, one of the EGFR Resisters founders and an advocate for patients with lung cancer. “My hope is that patients around the globe will join forces with the EGFR Resisters to create a strong collective voice in support of research. Working with ALCF strengthens our voice and extends our reach into important corridors of medical research and funding.”
Combining the efforts of ALCF and its research arm at the Addario Lung Cancer Medical Institute with the patient advocacy at EGFR Resisters will enable greater outreach to obtain research funding. The initiative also raises awareness about the patients who have donated information and tissue samples as well as provides researchers with a channel to recruit volunteers to participate in clinical trials for new therapies. ■